FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to a phthalazine ketone derivative, represented by formula 
in which radicals and symbols have values, given in the invention formula, a method of its obtaining, a pharmaceutical composition, containing the claimed derivative, and its application as a poly(ADP-ribose)polymerase (PARP) inhibitor.
EFFECT: obtaining the pharmaceutical composition for application as the poly(ADP-ribose)polymerase (PARP) inhibitor.
13 cl, 26 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
| IMIDAZOPYRAZINE OR IMIDAZODIAZEPINE DERIVATIVES, ACTIVE WITH RESPECT TO RECEPTOR CB2 | 2008 |
|
RU2540074C2 |
| HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS | 2018 |
|
RU2797822C2 |
| TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVE SALTS, METHODS FOR PREPARING THEM AND MEDICAL APPLICATION THEREOF | 2010 |
|
RU2523543C2 |
| COMPOUND BASED ON DIHYDRONAPTHYRIDINONE, METHOD OF ITS OBTAINING, AND ITS USE IN MEDICINE | 2021 |
|
RU2809869C1 |
| PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
| BICYCLIC 6-ALKYLIDENEPENEMS AS β-LACTAMASE INHIBITORS | 2003 |
|
RU2339640C2 |
| BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
| EP4 ANTAGONISTS | 2016 |
|
RU2761341C2 |
| CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
